Back to Search
Start Over
OSE Immunotherapeutics enters commercial and revenue sharing agreement with MSK in the field of CAR T-cell therapies
- Source :
- PharmaBiz. June 25, 2024
- Publication Year :
- 2024
-
Abstract
- OSE Immunotherapeutics SA announced that the company has entered into a commercial and revenue sharing agreement with Memorial Sloan Kettering Cancer Center (MSK), a leading global cancer centre. This exclusive [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.798857524